Figure S1 from New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity

Hangxiang Wang,Zhongjie Lu,Lijiang Wang,Tingting Guo,Jiaping Wu,Jianqin Wan,Liqian Zhou,Hui Li,Zhen Li,Donghai Jiang,Penghong Song,Haiyang Xie,Lin Zhou,Xiao Xu,Shusen Zheng

DOI: https://doi.org/10.1158/0008-5472.22416885.v1

2023-01-01

Abstract:The morphology of SNMs and PEGylated SNMs determined by TEM and DLS

What problem does this paper attempt to address?

Figure S4 from New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity

Hangxiang Wang,Zhongjie Lu,Lijiang Wang,Tingting Guo,Jiaping Wu,Jianqin Wan,Liqian Zhou,Hui Li,Zhen Li,Donghai Jiang,Penghong Song,Haiyang Xie,Lin Zhou,Xiao Xu,Shusen Zheng

DOI: https://doi.org/10.1158/0008-5472.22416873

2023-01-01

Abstract:Systemic toxicity of pSNMs in healthy ICR mice
Figure S3 from New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity

Hangxiang Wang,Zhongjie Lu,Lijiang Wang,Tingting Guo,Jiaping Wu,Jianqin Wan,Liqian Zhou,Hui Li,Zhen Li,Donghai Jiang,Penghong Song,Haiyang Xie,Lin Zhou,Xiao Xu,Shusen Zheng

DOI: https://doi.org/10.1158/0008-5472.22416879

2023-01-01

Abstract:Hydrolysis of prodrugs under different conditions analyzed by HPLC
Figure S2 from New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity

Hangxiang Wang,Zhongjie Lu,Lijiang Wang,Tingting Guo,Jiaping Wu,Jianqin Wan,Liqian Zhou,Hui Li,Zhen Li,Donghai Jiang,Penghong Song,Haiyang Xie,Lin Zhou,Xiao Xu,Shusen Zheng

DOI: https://doi.org/10.1158/0008-5472.22416882.v1

2023-01-01

Abstract:In vitro cytotoxicity of nanodrugs against human breast cancer MDA-MB-231 cells and human colorectal carcinoma LoVo cells
Figure S9-S14 from New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity

Hangxiang Wang,Zhongjie Lu,Lijiang Wang,Tingting Guo,Jiaping Wu,Jianqin Wan,Liqian Zhou,Hui Li,Zhen Li,Donghai Jiang,Penghong Song,Haiyang Xie,Lin Zhou,Xiao Xu,Shusen Zheng

DOI: https://doi.org/10.1158/0008-5472.22416864.v1

2023-01-01

Abstract:Histological analysis of tumors and major organs
Figure S5-S6 from New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity

Hangxiang Wang,Zhongjie Lu,Lijiang Wang,Tingting Guo,Jiaping Wu,Jianqin Wan,Liqian Zhou,Hui Li,Zhen Li,Donghai Jiang,Penghong Song,Haiyang Xie,Lin Zhou,Xiao Xu,Shusen Zheng

DOI: https://doi.org/10.1158/0008-5472.22416870

2023-01-01

Abstract:In vivo drug plasma concentration-time profile and drug tissue biodistribution
Figure S7-S8 from New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity

Hangxiang Wang,Zhongjie Lu,Lijiang Wang,Tingting Guo,Jiaping Wu,Jianqin Wan,Liqian Zhou,Hui Li,Zhen Li,Donghai Jiang,Penghong Song,Haiyang Xie,Lin Zhou,Xiao Xu,Shusen Zheng

DOI: https://doi.org/10.1158/0008-5472.22416867

2023-01-01

Abstract:Antitumor efficacy assessed in MDA-MB-231 and DU145 tumor-bearing mouse models
Supplementary Material and Methods from New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity

Hangxiang Wang,Zhongjie Lu,Lijiang Wang,Tingting Guo,Jiaping Wu,Jianqin Wan,Liqian Zhou,Hui Li,Zhen Li,Donghai Jiang,Penghong Song,Haiyang Xie,Lin Zhou,Xiao Xu,Shusen Zheng

DOI: https://doi.org/10.1158/0008-5472.22416861

2023-01-01

Abstract:Description of synthesis of compounds, additional experiments and procedures, and Table S1
Nanodelivery of a Self-Assembling Prodrug with Exceptionally High Drug Loading Potentiates Chemotherapy Efficacy.

Lulu Ren,Sihang Ren,Liwei Shu,Zihan Wang,Kewei Shi,Weidong Han,Hangxiang Wang

DOI: https://doi.org/10.1016/j.ijpharm.2021.120805

IF: 6.51

2021-01-01

International Journal of Pharmaceutics

Abstract:Nanomedicines have achieved several successful clinical applications for cancer therapy over the past decades. To date, numerous nanomedicine formats and design rationales have been proposed to improve pharmaceutical delivery and treatment efficacy. Despite these advances, the achievement of high drug loading and loading efficiencies of drug payloads in nanocarriers remains a technical challenge. In addition, study of the correlation between therapeutic potential and drug loading has been ignored. Here, using a self-assembling dimeric cabazitaxel prodrug, we show that the prodrug can be quantitatively entrapped within clinically approved polymer matrices for intravenous injection and that the drug loading in the nanoparticles (NPs) is tunable. The engineered NPs (NPs1-4) with different drug loading values exhibit dissimilar morphologies, release kinetics, in vitro cytotoxic activity, pharmacokinetic properties, tissue distribution, and in vivo anticancer efficacy and safety profiles. Furthermore, the effect of drug loading on the treatment outcomes was explored through detailed in vitro and in vivo studies. Intriguingly, among the constructed NPs, those comprising poly(ethylene glycol)-block-poly(D,L-lactic acid) (PEG-PLA) copolymers showed substantially prolonged pharmacokinetic properties in the blood circulation, which further promoted their intratumoral delivery and accumulation. Furthermore, the PEG-PLA-composed NPs with high drug loading (~50%) demonstrated favorable efficacy and safety profile in animal models. These data provide convincing evidence that the in vivo performance of a given self-assembling drug is not compromised by high drug loading in nanoplatforms, which may potentially reduce concerns over excipient-associated side effects and immunotoxicities. Overall, our study provides new insight into the rationale for designing more effective and less toxic delivery systems.
Cancer Nanomedicines Stabilized by Π-Π Stacking Between Heterodimeric Prodrugs Enable Exceptionally High Drug Loading Capacity and Safer Delivery of Drug Combinations.

Hangxiang Wang,Jianmei Chen,Chang Xu,Linlin Shi,Munire Tayier,Jiahui Zhou,Jun Zhang,Jiaping Wu,Zhijian Ye,Tao Fang,Weidong Han

DOI: https://doi.org/10.7150/thno.20028

IF: 11.6

2017-01-01

Theranostics

Abstract:Combination therapy using distinct mode-of-action drugs has sparked a rapidly growing interest because this paradigm holds promise for improving the therapeutic efficacy of anticancer therapy. However, the current drug combination therapy refers to administering individual drugs together, which is far from a perfect regimen for cancer patients. The aim of this work was to demonstrate that synergistic delivery of two chemotherapeutic drugs in a single nanoparticle reservoir could be achieved through the rational chemical ligation of the drugs followed by supramolecular nano-assembly via blending of the drugs with a minimal amount of matrix. Choosing 7-ethyl-10-hydroxycamptothecin and taxanes, which are rich in aromatic structures, as model compounds, we show that the heterodimeric conjugates of the two agents are miscible with lipids to form systemically injectable nanomedicines. The compatibility between the prodrug conjugates and lipid carriers is substantially augmented by the intermolecular π-π stacking and alleviated polarity, thus enabling an exceptionally high drug loading (DL) capacity (~92%) and a gratifyingly long drug retention time within the micellar core. We further observed superior therapeutic outcomes in a mouse tumor model without detecting accompanying systemic toxicity. This structure-based, self-assembled cancer nanomedicine increased the potency and drug tolerability in animals and thus offers a robust strategy for simultaneously formulating two or more drugs in single nanovehicles.
Drug-mediation Formation of Nanohybrids for Sequential Therapeutic Delivery in Cancer Cells.

Bingjie Zhou,Bozhen Wu,Jine Wang,Qihong Qian,Jing Wang,Hongbin Xu,Sun Yang,Pan Feng,Wu Chen,Yulin Li,Jia Jiang,Baosan Han

DOI: https://doi.org/10.1016/j.colsurfb.2017.12.046

2017-01-01

Abstract:In order to overcome the multidrug resistance (MDR) of tumor cells, it is very important to develop nanocarriers which can effectively load drugs while releasing them in a sequential way. Herein, nanohybrids with such properties have been fabricated by a first loading of one anticancer drug onto a silicate nanodisk (Laponite (LP), 25 nm in diameter and 0.92 nm in thickness) and a subsequent assembly with a pH sensitive poly(N-vinylpyrrolidone) (PVP) as a protective layer, followed by a loading of with another anticancer drug. The resulting nanohybrids (LDPM) present a high drug encapsulation efficiency and long-term colloidal stability. However, if the two drugs are loaded onto LP before PVP decoration, the formed particles tend to form microsized aggregates with poor colloidal stability. In vitro release study indicates that LDPM can deliver the anticancer drugs in a sequential way, which can be further accelerated under acidic microenvironments mimicking both solid tumor and endo-lysosomal compartments, exerting synergistic anticancer cytotoxicity. The drug-mediated formation of nanocarriers may enlighten a design of novel nanoplatform for co-delivery of therapeutic agents, beyond anticancer drugs, in a combinative way for drug delivery applications.
Structure‐Based Rational Design of Prodrugs to Enable Their Combination with Polymeric Nanoparticle Delivery Platforms for Enhanced Antitumor Efficacy

Hangxiang Wang,Haiyang Xie,Jiaping Wu,Xuyong Wei,Lin Zhou,Xiao Xu,Shusen Zheng

DOI: https://doi.org/10.1002/anie.201406685

2014-01-01

Angewandte Chemie International Edition

Abstract:Drug-loaded nanoparticles (NPs) are of particular interest for efficient cancer therapy due to their improved drug delivery and therapeutic index in various types of cancer. However, the encapsulation of many chemotherapeutics into delivery NPs is often hampered by their unfavorable physicochemical properties. Here, we employed a drug reform strategy to construct a small library of SN-38 (7-ethyl-10-hydroxycamptothecin)-derived prodrugs, in which the phenolate group was modified with a variety of hydrophobic moieties. This esterification fine-tuned the polarity of the SN-38 molecule and enhanced the lipophilicity of the formed prodrugs, thereby inducing their self-assembly into biodegradable poly(ethylene glycol)-block-poly(d,l-lactic acid) (PEG-PLA) nanoparticulate structures. Our strategy combining the rational engineering of prodrugs with the pre-eminent features of conventionally used polymeric materials should open new avenues for designing more potent drug delivery systems as a therapeutic modality.
Polyamine‐Responsive Morphological Transformation of a Supramolecular Peptide for Specific Drug Accumulation and Retention in Cancer Cells

Chen Sun,Ziyi Wang,Kuikun Yang,Ludan Yue,Qian Cheng,Yan‐long Ma,Siyu Lu,Guosong Chen,Ruibing Wang

DOI: https://doi.org/10.1002/smll.202101139

IF: 13.3

2021-06-10

Small

Abstract:The precise accumulation and extended retention of nanomedicines in the tumor tissue has been highly desired for cancer therapy. Here a novel supramolecular-peptide derived nanodrug (SPN) that can be transformed to microfibers in response to intracellular polyamine in cancer cells for significantly enhanced tumor specific accumulation and retention is developed. The supramolecular-peptide is constructed via the non-covalent interactions between cucurbit[7]uril (CB[7]) and Phe on Phe-Phe-Val-Leu-Lys-camptothecin conjugates (FFVLK-CPT, PC). The resultant amphiphilic supramolecular complex subsequently self-assembles into nanoparticles with a hydrodynamic diameter of 164.2 ± 3.7 nm. Upon internalization into spermine-overexpressed cancer cells, the CB[7]-Phe host–guest pairs can be competitively dissociated by spermine and can release free PC, which immediately form β-sheet structures and subsequently reorganize into microfibers, leading to dramatically improved accumulation, retention, and sustained release of CPT in tumor cells for highly effective cancer therapy. Accordingly, this SPN exhibit rather low toxicity against non-cancerous cells due to the morphological stability and fast exocytosis of the nanodrugs in those cells without abundant spermine. This study reports the first supramolecular peptide capable of polyamine-responsive "nanoparticle-to-microfiber" transformation for specific tumor therapy with minimal side effects. This work also offers novel insights to the design and development of stimuli-responsive nanomaterials as precision medicine.

materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology
Self-assembly of Pentapeptides into Morphology-Adaptable Nanomedicines for Enhanced Combinatorial Chemo-Photodynamic Therapy

Zhifei Cheng,Yuanyuan Cheng,Qian Chen,Mingming Li,Jie Wang,Hui Liu,Mengwen Li,Yashan Ning,Zhilin Yu,Yinsong Wang,Hao Wang

DOI: https://doi.org/10.1016/j.nantod.2020.100878

IF: 17.4

2020-01-01

Nano Today

Abstract:The persistent morphology of conventional delivering systems limits their capability to further simultaneously optimize pharmokinetics and overcome the physiological delivering barriers. To address this challenge, here we report nanomedicines delivered by morphology-adaptable platforms for enhanced drug delivering and combinatorial chemo-photodynamic therapeutic efficacy. The nanomedicines were created by co-assembling a pentapeptide (AmpF) containing a 4-amino proline (Amp) with its two derivatives CPT-AmpF and IR820-AmpF, which are functionalized by drug camptothecin (CPT) and photo-sensitizer new indocyanine green IR820, respectively. The resulting nanomedicines formed superhelices and nanoparticles under neutral and mild acidic pH conditions. Cellular experiments revealed that the nanomedicines were up-taken by breast cancer cells via an endo-/lysosome-mediated mechanism, thus allowing the nanomedicines to undergo a reversible superhelice-nanoparticle morphological transition during the delivering pathway. Therefore, the superhelcial morphology of the nanomedicines prolonged blood circulation and tumor retention, whereas the transformed nanoparticles facilitated penetration and accumulation at tumor sites. Compared to the morphology-persistent counterparts, the improved delivering efficiency of the adaptable nanomedicines resulted in the enhanced combinatorial chemophotodynamic therapy against breast tumors, thus potentially leading to a facile and versatile strategy for drug delivery and paving the way toward new-generation nanomedicines in the future. (C) 2020 Elsevier Ltd. All rights reserved.
A self-assembling prodrug nanosystem to enhance metabolic stability and anticancer activity of gemcitabine

Mei Cong,Guangling Xu,Shaoyou Yang,Jing Zhang,Wenzheng Zhang,Dinesh Dhumal,Erik Laurini,Kaiyue Zhang,Yi Xia,Sabrina Pricl,Ling Peng,Weidong Zhao

DOI: https://doi.org/10.1016/j.cclet.2021.11.083

IF: 9.1

2022-05-01

Chinese Chemical Letters

Abstract:Self-assembly is a powerful approach in molecular engineering for biomedical applications, in particular for creating self-assembling prodrugs. Here, we report a self-assembling prodrug of the anticancer drug gemcitabine (Gem) based on amphiphilic dendrimer approach. The prodrug reported in this study demonstrates high drug loading (40%) and robust ability to self-assemble into small nanomicelles, which increase the metabolic stability of Gem and enable entry into cells via endocytosis, hence bypassing transport-mediated uptake. In addition, this prodrug nanosystem exhibited an effective pH- and enzyme-responsive release of Gem, resulting in enhanced anticancer activity and reduced toxicity. Harboring advantageous features of both prodrug- and nanotechnology-based drug delivery, this self-assembling Gem prodrug nanosystem constitutes a promising anticancer candidate. This study also offers new perspectives of the amphiphilic dendrimer nanoplatforms for the development of self-assembling prodrugs.

chemistry, multidisciplinary
Impact of the Amount of PEG on Prodrug Nanoassemblies for Efficient Cancer Therapy

Yaqiao Li,Lingxiao Li,Qianhui Jin,Tian Liu,Jin Sun,Yongjun Wang,Zhijun Yang,Zhonggui He,Bingjun Sun

DOI: https://doi.org/10.1016/j.ajps.2022.02.002

IF: 9.273

2022-01-01

Asian Journal of Pharmaceutical Sciences

Abstract:PEGylation has been widely used to improve the pharmacokinetic properties of prodrug self-assembled nanoparticles (prodrug-SANPs). However, the impacts of the amount of PEG on the self-assemble stability, cellular uptake, pharmacokinetics, and antitumor efficacy of prodrug-SANPs are still unknown. Herein, selenoether bond bridged docetaxel dimeric prodrug was synthesized as the model prodrug. Five prodrug-SANPs were designed by using different mass ratios of prodrugs to PEG (Wprodrug/WDSPE-mPEG2000 = 10:0, 9:1, 8:2, 7:3 and 6:4), and defined as Pure drug NPs, 9:1NPs, 8:2NPs, 7:3 NPs and 6:4 NPs, respectively. Interestingly, 8:2 NPs formed the most compact nanostructure, thus improving the self-assemble stability and pharmacokinetics behavior. In addition, the difference of these prodrug-SANPs in cellular uptake was investigated, and the influence of PEG on cytotoxicity and antitumor efficacy was also clarified in details. The 8:2 NPs exhibited much better antitumor efficacy than other prodrug-SANPs and even commercial product. Our findings demonstrated the pivotal role of the amount of PEG on prodrug-SANPs.
Tumor Microenvironment-Activated Self-Recognizing Nanodrug Through Directly Tailored Assembly of Small-Molecules for Targeted Synergistic Chemotherapy.

Yang Li,Jinyan Lin,Zhixiong Cai,Peiyuan Wang,Qiang Luo,Cuiping Yao,Yun Zhang,Zhenqing Hou,Jingfeng Liu,Xiaolong Liu

DOI: https://doi.org/10.1016/j.jconrel.2020.02.025

IF: 11.467

2020-01-01

Journal of Controlled Release

Abstract:Carrier-free nanodrug via small-molecule assembly is a promising alternative strategy for tumor therapy. Thus, developing a self-recognizing carrier-free nanodrug without introduction of foreign ligand is very attractive to meet both targeting and therapeutic requirements while reducing structural complexity. Here we fabricated a tumor microenvironment-activated self-targeting nanodrug, via co-assembly of hydroxycamptothecin (HCPT) and bi-functional methotrexate (MTX, not only has antitumor effect but also shows innate affinity towards folate receptors) followed by surface covering through acidity-responsive polyethylene glycol (PEG). Notably, the morphology and size of MTX-HCPT nanodrug could be tuned by varying the drug-to-drug ratio and assembly time. The PEG shell of our nanodrug could be detached in response to acidic tumor microenvironment, and then MTX could be exposed for self-targeting to enhance tumor cell uptake. Subsequently, the shell-detached nanodrug could be dissociated in relatively stronger acidic lysosomal environment, resulting in burst release of both drugs. Further in vitro and in vivo studies demonstrated that our nanodrug showed a ~2.98-fold increase in cancer cell uptake, a ~1.25-fold increase in drug accumulation at tumor site, a significantly lower CI50 value of ~0.3, a ~27.3% improvement in tumor inhibition comparing with the corresponding non-responsive nanodrug. Taken together, the here reported tumor microenvironment-activated self-recognizing nanodrug might be an extremely promising strategy for synergistically enhancing chemotherapy efficiency with minimized side effects.
Triglyceride-Mimetic Structure-Gated Prodrug Nanoparticles for Smart Cancer Therapy

Chutong Tian,Jingjing Guo,Yifan Miao,Shunzhe Zheng,Bingjun Sun,Mengchi Sun,Qing Ye,Wenxue Liu,Shuang Zhou,Ken-ichiro Kamei,Zhonggui He,Jin Sun

DOI: https://doi.org/10.1021/acs.jmedchem.1c01328

IF: 8.039

2021-11-01

Journal of Medicinal Chemistry

Abstract:Off-target drug release and insufficient drug delivery are the main obstacles for effective anticancer chemotherapy. Prodrug-based self-assembled nanoparticles bioactivated under tumor-specific conditions are one of the effective strategies to achieve on-demand drug release and effective tumor accumulation. Herein, stimuli-activable prodrugs are designed yielding smart tumor delivery by combination of the triglyceride-mimic (TG-mimetic) prodrug structure and disulfide bond. Surprisingly, these prodrugs can self-assemble into uniform nanoparticles (NPs) with a high drug loading (over 40%) and accumulate in tumor sites specifically. The super hydrophobic TG structure can act as a gate that senses lipase to selectively control over NP dissociation and affect the glutathione-triggered prodrug activation. In addition, the impacts of the double bonds in the prodrug NPs on parent drug release and the following cytotoxicity, pharmacokinetics, and antitumor efficiency are further demonstrated. Our findings highlight the promising potential of TG-mimetic structure-gated prodrug nanoparticles for tumor-specific drug delivery.

chemistry, medicinal
Self‐Assembling Prodrugs by Precise Programming of Molecular Structures that Contribute Distinct Stability, Pharmacokinetics, and Antitumor Efficacy

hangxiang wang,haiyang xie,jianguo wang,jiaping wu,xueji ma,lingling li,xuyong wei,qi ling,penghong song,lin zhou,xiao xu,shusen zheng

DOI: https://doi.org/10.1002/adfm.201501953

IF: 19

2015-01-01

Advanced Functional Materials

Abstract:The availability of precisely modulated chemical modifications dramatically affects the physicochemical properties of pristine drugs and should facilitate the amphiphilic self-assembly of prodrugs into supramolecular nano-prodrugs (SNPs). However, rationally designing such prodrugs to achieve favorable clinical outcomes still remains a challenge. Here, a library of prodrugs through site-specific attachment of a variety of lipophilic moieties to the antitumor agent SN-38 (7-ethyl-10-hydroxycamptothecin) is constructed. Taking advantage of the role of hydroxyl groups as solvophilic moieties, these prodrugs exhibit self-assembly in aqueous environments, allowing for the identification of five prodrugs capable of self-assembling into SNPs at high drug concentrations. Importantly, in vivo studies demonstrate that the antitumor activity of the SNPs correlates well with their stability and long-term circulation. In addition, the modular feature of this SNP design strategy offers the opportunity to readily incorporate additional valuable functionalities (e.g., tumor-specific targeting ligands) to the particle surface, which is further exploited to improve antitumor efficacy in mouse xenograft models. Thus, this structure-based reconstruction of SN-38 molecules significantly improves the potency of SNPs for clinical use. These results also provide novel mechanistic insights into the rational design of prodrugs.
Single Molecular Nanomedicines Based on Macrocyclic Carrier-Drug Conjugates for Concentration-Independent Encapsulation and Precise Activation of Drugs

Shun-Yu Yao,An-Kang Ying,Ze-Tao Jiang,Yuan-Qiu Cheng,Wen-Chao Geng,Xin-Yue Hu,Kang Cai,Dong-Sheng Guo

DOI: https://doi.org/10.1021/jacs.4c03238

2024-05-22

Abstract:Nanomedicines often rely on noncovalent self-assembly and encapsulation for drug loading and delivery. However, challenges such as reproducibility issues due to the multicomponent nature, off-target activation caused by premature drug release, and complex pharmacokinetics arising from assembly dissociation have hindered their clinical translation. In this study, we introduce an innovative design concept termed single molecular nanomedicine (SMNM) based on macrocyclic carrier-drug conjugates. Through the covalent linkage of two chemotherapy drugs to a hypoxia-cleavable macrocyclic carrier, azocalix[4]arene, we obtained two self-included complexes to serve as SMNMs. The intramolecular inclusion feature of the SMNMs has not only demonstrated comprehensive shielding and protection for the drugs but also effectively prevented off-target drug leakage, thereby significantly reducing their side effects and enhancing their antitumor therapeutic efficacy. Additionally, the attributes of being a single component and molecularly dispersed confer advantages such as ease of preparation and good reproducibility for SMNMs, which is desirable for clinical applications.
Redox-Responsive Polyphosphate Nanosized Assemblies: A Smart Drug Delivery Platform for Cancer Therapy

Jinyao Liu,Yan Pang,Wei Huang,Zhaoyang Zhu,Xinyuan Zhu,Yongfeng Zhou,Deyue Yan

DOI: https://doi.org/10.1021/bm2005164

2011-01-01

Biomacromolecules

Abstract:Novel redox-responsive polyphosphate nanosized assemblies based on amphiphilic hyperbranched multiarm copolyphosphates (HPHSEP-star-PEP(x)) with backbone redox-responsive, good biocompatibility, and biodegradability simultaneously have been designed and prepared successfully. The hydrophobic core and hydrophilic multiarm of HPHSEP-star-PEP(x) are composed of hyperbranched and linear polyphosphates, respectively. Benefiting from the amphiphilicity, HPHSEP-star-PEP(x) can self-assemble into spherical micellar nanoparticles in aqueous media with tunable size from about 70 to 100 nm via adjusting the molecular weight of PEP multiarm. Moreover, HPHSEP-star-PEP(x) micellar structure can be destructed under reductive environment and result in a triggered drug release behavior. The glutathione-mediated intracellular drug delivery was investigated against a HeLa human cervical carcinoma cell line, and the results indicate that doxorubicin-loaded (DOX-loaded) HPHSEP-star-PEP(x) micelles show higher cellular proliferation inhibition against glutathione monoester pretreated HeLa cells than that of the nonpretreated ones. In contrast, the DOX-loaded micelles exhibit lower inhibition against buthionine sulfoximine pretreated HeLa cells. These results suggest that such redox-responsive polyphosphate micelles can rapidly deliver anticancer drugs into the nuclei of tumor cells enhancing the inhibition of cell proliferation and provide a favorable platform to construct excellent drug delivery systems for cancer therapy.

Figure S1 from New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity

Figure S4 from New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity

Figure S3 from New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity

Figure S2 from New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity

Figure S9-S14 from New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity

Figure S5-S6 from New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity

Figure S7-S8 from New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity

Supplementary Material and Methods from New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity

Nanodelivery of a Self-Assembling Prodrug with Exceptionally High Drug Loading Potentiates Chemotherapy Efficacy.

Cancer Nanomedicines Stabilized by Π-Π Stacking Between Heterodimeric Prodrugs Enable Exceptionally High Drug Loading Capacity and Safer Delivery of Drug Combinations.

Drug-mediation Formation of Nanohybrids for Sequential Therapeutic Delivery in Cancer Cells.

Structure‐Based Rational Design of Prodrugs to Enable Their Combination with Polymeric Nanoparticle Delivery Platforms for Enhanced Antitumor Efficacy

Polyamine‐Responsive Morphological Transformation of a Supramolecular Peptide for Specific Drug Accumulation and Retention in Cancer Cells

Self-assembly of Pentapeptides into Morphology-Adaptable Nanomedicines for Enhanced Combinatorial Chemo-Photodynamic Therapy

A self-assembling prodrug nanosystem to enhance metabolic stability and anticancer activity of gemcitabine

Impact of the Amount of PEG on Prodrug Nanoassemblies for Efficient Cancer Therapy

Tumor Microenvironment-Activated Self-Recognizing Nanodrug Through Directly Tailored Assembly of Small-Molecules for Targeted Synergistic Chemotherapy.

Triglyceride-Mimetic Structure-Gated Prodrug Nanoparticles for Smart Cancer Therapy

Self‐Assembling Prodrugs by Precise Programming of Molecular Structures that Contribute Distinct Stability, Pharmacokinetics, and Antitumor Efficacy

Single Molecular Nanomedicines Based on Macrocyclic Carrier-Drug Conjugates for Concentration-Independent Encapsulation and Precise Activation of Drugs

Redox-Responsive Polyphosphate Nanosized Assemblies: A Smart Drug Delivery Platform for Cancer Therapy